Citrate anticoagulation in pediatric continuous venovenous hemofiltration

Pediatric Nephrology

Volumn 19, Issue 2, 2004, Pages 208-212

  Elhanan, Nahum ^a   Skippen, Peter ^a   Nuthall, Gabrielle ^b   Krahn, Gordon ^a   Seear, Michael ^a  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

Citrate anticoagulation; Continuous renal replacement therapy; Hemofiltration; Renal dialysis

Indexed keywords

ACD FORMULA A; BICARBONATE; CALCIUM; CALCIUM CHLORIDE; CITRIC ACID; CREATININE; HEPARIN; POTASSIUM; SODIUM; UREA;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ANTICOAGULATION; ARTICLE; BICARBONATE BLOOD LEVEL; BLEEDING; CALCIUM BLOOD LEVEL; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG EXCRETION; DRUG INFUSION; DRUG METABOLISM; DRUG TOLERABILITY; FEMALE; FILTER; HEART DISEASE; HEMOFILTRATION; HUMAN; HYPERKALEMIA; HYPOCALCEMIA; INTENSIVE CARE UNIT; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SURVIVAL; UREA NITROGEN BLOOD LEVEL; UREMIA; UROGENITAL SYSTEM PARAMETERS;

ADOLESCENT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; CITRATES; CRITICAL ILLNESS; FEMALE; HEMOFILTRATION; HUMANS; HYPERKALEMIA; INFANT; MALE; RETROSPECTIVE STUDIES; UREMIA;

EID: 0842323883     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1328-5     Document Type: Article

References (25)

1. Manns M, Sigler M, Teehan B (1998) Continuous renal replacement therapies: an update. Am J Kidney Dis 32:185-207
2. Werner H, Herbertson M, Seear M (1993) The operating characteristics of three CAVH circuit designs in a pediatric sized animal model. Pediatr Nephrol 7:189-193
3. Maxvold N, Smoyer W, Custer J, Bunchman T (2000) Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a comparison between CVVH and CVVHD therapies. Crit Care Med 28:1161-1165
4. Ronco C, Ricci Z, Bellomo R (2001) Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role of continuous veno-venous hemofiltration. Curr Opin Nephrol Hypertens 10:755-761
5. Goldstein S, Currier H, Graf C (2001) Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 107:1309-1312
6. Van de Wetering J, Westendorp R, Stolk B (1996) Heparin use in continuous renal replacement procedures: the struggle between filer coagulation and patient hemorrhage. J Am Soc Nephrol 7:145-150
7. Owings J, Bagley M, Gosselin R (1996) Effect of critical injury on plasma antithrombin activity: low antithrombin levels are associated with thromboembolic complications. J Trauma 41:396-405
8. Reeves J, Cumming A, Gallagher L (1999) A controlled trial of low molecular weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Crit Care Med 27:2224-2228
9. Kim J, Vincent C, Teng C (1989) A novel approach to anticoagulation control. ASAIO Trans 25:644-646
10. Kozek-Langenecker S, Kettner S, Oismueller (1998) Anticoagulation with prostaglandin E-1 and unfractionated heparin during continuous venovenous hemofiltration. Crit Care Med 26:1208-1212
11. Hiraide S, Tazaki O, Fujii N (1994) Cardiac tamponade secondary to hemorrhagic pericarditis during continuous hemofiltration for renal failure. The role of the anticoagulant. Ren Fail 16:299-301
12. Tan H, Baldwin I, Bellomo R (2000) Continuous veno-venous hemofiltration without anticoagulation in high risk patients. Intensive Care Med 26:1652-1657
13. Morita Y, Johnson R, Dorn R, Hall D (1961) Regional anticoagulation during hemodialysis using citrate. Am J Med Sci 242:32-42
14. Mehta R, McDonald B, Aguilar M, Ward D (1990) Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976-981
15. Palsson R, Niles J (1999) Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55:1991-1997
16. Kutsogiannis D, Mayers I, Chin W, Gibney R (2000) Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 35:807-811
17. Bunchman T, Maxvold N, Barnett J, Hutchings A, Benfield M (2002) Pediatric hemofiltration: normocarb dialysate solution with citrate anticoagulation. Pediatric Nephrol 17:150-154
18. Chadha V, Garg U, Warady B, Alon U (2002) Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 17:819-824
19. Dzik, W, Kirkley S (1988) Citrate toxicity during massive blood transfusion. Transfus Med Rev 2:76-94
20. Nuthall G, Skippen P, Daoust C, Al-Jofan F, Seear M (2002) Citrate anticoagulation in a piglet model of pediatric continuous renal replacement therapy. Crit Care Med 30:900-903
21. Meier-Kriesche H, Gitomer J, Finkel K, Du Bose T (2001) Increased total to ionised calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 29:748-752
22. Scott V, De Wolf A, Kong Y (1996) Ionized hypomagnesemia in patients undergoing orthotopic liver transplantation: a complication of citrate intoxication. Liver Transpl Surg 2:343-347
23. Bunker J, Bendixen H, Murphy A (1962) Hemodynamic effects of intravenously administered sodium citrate. N Engl J Med 266:372-377
24. Rebeyka I, Yeh T, Hanan S (1990) Altered contractile response in neonatal myocardium to citrate-phosphate-dextrose infusion. Circulation 82 [Suppl 5]:IV367-IV370
25. Abbott T (1983) Changes in serum calcium fractions and citrate concentrations during massive blood transfusions and cardio-pulmonary bypass. Br J Anaesth 55:753-760